|
RUFY2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.632000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.887800E-01 |
| Normal-vs-Stage2 |
7.021200E-01 |
| Normal-vs-Stage3 |
9.528000E-02 |
| Normal-vs-Stage4 |
2.668400E-02 |
| Stage1-vs-Stage2 |
9.202400E-01 |
| Stage1-vs-Stage3 |
8.304300E-03 |
| Stage1-vs-Stage4 |
1.059830E-03 |
| Stage2-vs-Stage3 |
1.187010E-01 |
| Stage2-vs-Stage4 |
7.002300E-02 |
| Stage3-vs-Stage4 |
6.094200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.890400E-01 |
| Normal-vs-AfricanAmerican |
7.299200E-01 |
| Normal-vs-Asian |
7.966300E-02 |
| Caucasian-vs-AfricanAmerican |
9.929800E-01 |
| Caucasian-vs-Asian |
1.636360E-01 |
| AfricanAmerican-vs-Asian |
1.534000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.327200E-01 |
| Normal-vs-Female |
3.637800E-01 |
| Male-vs-Female |
1.908390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.717200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.066600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.728800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.457000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.248800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.897400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.681200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.152800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.761200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.359800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.5754000000019E-05 |
| Normal-vs-Grade 2 |
1.185210E-01 |
| Normal-vs-Grade 3 |
8.467800E-02 |
| Normal-vs-Grade 4 |
2.813300E-04 |
| Grade 1-vs-Grade 2 |
2.855700E-02 |
| Grade 1-vs-Grade 3 |
1.47520000004508E-06 |
| Grade 1-vs-Grade 4 |
4.54249999837231E-08 |
| Grade 2-vs-Grade 3 |
2.014800E-04 |
| Grade 2-vs-Grade 4 |
1.72030000022971E-07 |
| Grade 3-vs-Grade 4 |
1.364190E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.801800E-02 |
| Normal-vs-ccB subtype |
2.245700E-02 |
| ccA subtype-vs-ccB subtype |
1.91130000004591E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.887600E-01 |
| Normal-vs-N1 |
1.172800E-01 |
| N0-vs-N1 |
2.232400E-01 |
|
|
